Announcements Trials

Browse Landscape

Sponsor

Conditions

Motor Activity 9 Neoplasms 6 Pancreatic Neoplasms 3 Lung Neoplasms 3 Breast Neoplasms 3 Esophageal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Rectal Neoplasms 1 Peripheral Nervous System Diseases 1 Neurocognitive Disorders 1 Disease 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Cognitive Dysfunction 1

Interventions

Cyclophosphamide 9 fludarabine 7 Dexamethasone 7 pomalidomide 6 Rituximab 6 pembrolizumab 5 selinexor 4 obinutuzumab 4 glofitamab 4 Lenalidomide 4 daratumumab 3 belantamab mafodotin 3 Temozolomide 3 Gemcitabine 3 Etoposide 3 Bortezomib 3 zanubrutinib 2 venetoclax 2 tocilizumab 2 fludarabine phosphate 2 enzalutamide 2 cemiplimab 2 carfilzomib 2 abemaciclib 2 PF06821497 2 Mesna 2 Lisaftoclax 2 Injections 2 Immunotherapy, Adoptive 2 Granulocyte Colony-Stimulating Factor 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

0 trials

Recent Start date Enrollment

Recurrence × Exercise × 30 days × Clear all

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡